Proclin Research
Global PresenceComplianceAboutContact
Get in Touch

Stay ahead of clinical research.

Insights, news and trial updates from Proclin — straight to your inbox.

PROCLIN

A global clinical research organization delivering collaboration, control and data integrity across every phase of clinical development.

Salcon Ras Vilas, 501 & 501A, District Centre, Saket, New Delhi 110017

+91 755 3586 226

medical@proclinresearch.com

Services

  • Clinical Operations
  • In-House CTMS
  • Monitoring & Regulatory
  • Site Partnership

© 2026 Proclin Research Private Limited. All rights reserved.

21 CFR Part 11•GDPR•ICH-GCP•Admin
Insights

Compliance

ICH E6 (R3) is Live — What Actually Changes for Your Study

Regulatory Team2025-08-12 7 min
ICH E6 (R3) is Live — What Actually Changes for Your Study

The ICH E6 (R3) Good Clinical Practice guideline became Step 5 on 23 July 2025. Unlike R2, R3 is written for a modern, risk-based, digitally-enabled trial ecosystem.

Top shifts you should plan around now:

  • Principles-first structure — the annex now spells out how principles apply to interventional and decentralized designs.
  • Proportionality — quality-management effort must match risk to participants and to reliability of results.
  • Data governance — full lifecycle traceability from source through report, regardless of tool.
  • Sponsor oversight of vendors — including AI and analytics providers.

Proclin's SOPs, CTMS, IWRS/RTSM and monitoring workflows were re-baselined for R3 through the summer of 2025 — including a live training we ran for OUCRU Nepal.

Written by Regulatory Team

Get in Touch

Related Insights

A Practical Guide to 21 CFR Part 11 Readiness

Strengthening GDPR Alignment Across Global Programs

Reimagining Ophthalmology Trials Through Decentralization